The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 37.51 USD. With the latest stock price at 23.73 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 58.1%.
Based on the latest price of 23.73 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 58.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 10.1% | 8.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 27.58 - 55.75 | 37.51 |
| Upside | 16.2% - 134.9% | 58.1% |